Effects of Aldosterone Antagonism on Insulin-mediated Microvascular Function in Subjects With the Metabolic Syndrome
Phase of Trial: Phase IV
Latest Information Update: 20 May 2017
At a glance
- Drugs Eplerenone (Primary)
- Indications Hypertension; Insulin resistance
- Focus Pharmacodynamics; Therapeutic Use
- 18 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov.
- 10 Mar 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.
- 14 Jan 2014 Planned initiation date changed from 1 Sep 2013 to 1 Oct 2013, according to ClinicalTrials.gov record.